Page last updated: 2024-10-20

uric acid and Cognition Disorders

uric acid has been researched along with Cognition Disorders in 34 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"The association of serum uric acid, cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) and longitudinal cognitive decline was evaluated using the AD Neuroimaging Initiative database."7.83Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline? ( Ham, JH; Lee, JJ; Lee, PH; Lee, WW; Sohn, YH; Ye, BS, 2016)
"High normal concentrations of serum uric acid (UA) are associated with mild cognitive dysfunction and increased cerebral ischemia as indexed by white matter hyperintensity volumes."7.74Cerebral ischemia mediates the effect of serum uric acid on cognitive function. ( Gordon, B; Jinnah, HA; Kraut, M; Schretlen, DJ; Vannorsdall, TD, 2008)
"The uric acid(UA) level was measured using automatic biochemical analyzer, and cognitive function was assessed by Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and Stroop color-word test."5.91Association between uric acid and cognitive dysfunction: A cross-sectional study with newly diagnosed, drug-naïve with bipolar disorder. ( Chen, J; Li, S; Lu, X; Qiu, Y; Tang, H; Teng, Z; Wang, B; Wu, H; Xiang, H; Xu, X; Zhao, Z, 2023)
"Hyperuricemia was defined as serum UA ≥7 mg/dl in men and ≥ 6 mg/dl in women."5.56The relationship between serum uric acid and cognitive function in patients with chronic heart failure. ( Lu, C; Niu, W; Yang, H, 2020)
"Uric acid has an anti-oxidative effect."5.42Association of serum uric acid level with cognitive function among patients with multiple system atrophy. ( Cao, B; Ou, R; Shang, HF; Wei, QQ; Yang, J, 2015)
"Uric acid is a risk factor of cardiovascular disease, as well as a major natural antioxidant, prohibiting the occurrence of cellular damage."5.35Serum uric acid and cognitive function and dementia. ( Breteler, MM; Euser, SM; Hofman, A; Westendorp, RG, 2009)
" Disturbance in purine metabolism pathway and a higher level of serum uric acid, called hyperuricemia, is a risk factor of CKD, and it has been linked to increased prevalence and progression of the disease."3.88Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment. ( Bhattacharjee, A; Borah, A; Mazumder, MK; Phukan, BC, 2018)
"The association of serum uric acid, cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) and longitudinal cognitive decline was evaluated using the AD Neuroimaging Initiative database."3.83Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline? ( Ham, JH; Lee, JJ; Lee, PH; Lee, WW; Sohn, YH; Ye, BS, 2016)
" In ET patients, cognitive scores were correlated with serum levels of uric acid, education, tremor Rating Scale for Tremor-motor subscale score and depression levels (r = 0."3.80[Cognitive dysfuctions associated with essential tremor and Parkinson's disease]. ( Chen, J; Chen, Y; Liu, C; Mao, C; Wu, Y; Yao, J, 2014)
"High normal concentrations of serum uric acid (UA) are associated with mild cognitive dysfunction and increased cerebral ischemia as indexed by white matter hyperintensity volumes."3.74Cerebral ischemia mediates the effect of serum uric acid on cognitive function. ( Gordon, B; Jinnah, HA; Kraut, M; Schretlen, DJ; Vannorsdall, TD, 2008)
"A total of 104 patients with Parkinson's disease were divided into two groups: those with cognitive impairment and those without."2.74[Study on uric acid and the related factors associated with cognition in the patients with Parkinson's disease]. ( Liu, CF; Luo, WF; Mao, CJ; Wang, L; Wang, LJ; Wang, XJ, 2009)
"The uric acid(UA) level was measured using automatic biochemical analyzer, and cognitive function was assessed by Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and Stroop color-word test."1.91Association between uric acid and cognitive dysfunction: A cross-sectional study with newly diagnosed, drug-naïve with bipolar disorder. ( Chen, J; Li, S; Lu, X; Qiu, Y; Tang, H; Teng, Z; Wang, B; Wu, H; Xiang, H; Xu, X; Zhao, Z, 2023)
"Hyperuricemia was defined as serum UA ≥7 mg/dl in men and ≥ 6 mg/dl in women."1.56The relationship between serum uric acid and cognitive function in patients with chronic heart failure. ( Lu, C; Niu, W; Yang, H, 2020)
"Uric acid (UA) is a powerful antioxidant that may have neuroprotective properties, yet it is also a risk factor of vascular disease that predisposes individuals to cognitive impairment."1.46A Prospective Study on the Association between Uric Acid and Cognitive Function among Middle-Aged and Older Chinese. ( Sun, Y; Wang, T; Wu, Y; Zhai, L; Zhang, D, 2017)
"Uric acid (UA) is a purine metabolite that in most mammals is degraded by the hepatic enzyme uricase to allantoin."1.43Uric Acid Induces Cognitive Dysfunction through Hippocampal Inflammation in Rodents and Humans. ( Cen, X; Gao, F; Hu, J; Jie, H; Li, D; Li, Y; Lu, W; Shao, X; Zhao, Y; Zuo, Z, 2016)
"Uric acid (UA) has a contradictory effect on cognitive function and several lines of evidence suggest that UA may modulate outcome in neurological diseases."1.42Relation between uric acid and Alzheimer's disease in elderly Jordanians. ( Al-khateeb, E; Al-khateeb, M; Al-Musawi, H; Al-Shweiki, S; Althaher, A; Azzouqah, O; Shafagoj, Y, 2015)
"Uric acid has been associated as a risk factor for cardiovascular disease."1.42Lower uric Acid linked with cognitive dysfunction in the elderly. ( Arias-Carrión, O; Barraza-Salas, M; Cisneros-Martínez, J; Méndez-Hernández, E; Ruano-Calderón, L; Salas-Pacheco, J; Téllez-Valencia, A, 2015)
"Uric acid has an anti-oxidative effect."1.42Association of serum uric acid level with cognitive function among patients with multiple system atrophy. ( Cao, B; Ou, R; Shang, HF; Wei, QQ; Yang, J, 2015)
"Cognitive changes are common in Parkinson's disease (PD)."1.37Uric acid and cognition in Parkinson's disease: a follow-up study. ( Annanmaki, T; Hakkinen, P; Murros, K; Parviainen, T; Pohja, M, 2011)
"Uric acid is a risk factor of cardiovascular disease, as well as a major natural antioxidant, prohibiting the occurrence of cellular damage."1.35Serum uric acid and cognitive function and dementia. ( Breteler, MM; Euser, SM; Hofman, A; Westendorp, RG, 2009)
"Cognitive dysfunction is common in Parkinson's disease (PD)."1.35Uric acid associates with cognition in Parkinson's disease. ( Annanmaki, T; Hokkanen, L; Murros, K; Pessala-Driver, A, 2008)

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.88)18.7374
1990's0 (0.00)18.2507
2000's8 (23.53)29.6817
2010's22 (64.71)24.3611
2020's2 (5.88)2.80

Authors

AuthorsStudies
Fernández, JR1
Sweet, ES1
Welsh, WJ1
Firestein, BL1
Li, S1
Lu, X2
Qiu, Y1
Teng, Z1
Zhao, Z1
Xu, X1
Tang, H1
Xiang, H1
Chen, J2
Wang, B1
Wu, H1
Niu, W1
Yang, H1
Lu, C1
Wang, T1
Wu, Y3
Sun, Y1
Zhai, L1
Zhang, D2
Mazumder, MK1
Phukan, BC1
Bhattacharjee, A1
Borah, A1
Al-khateeb, E1
Althaher, A1
Al-khateeb, M1
Al-Musawi, H1
Azzouqah, O1
Al-Shweiki, S1
Shafagoj, Y1
Yao, J1
Chen, Y1
Mao, C1
Liu, C1
Vannorsdall, TD2
Kueider, AM1
Carlson, MC1
Schretlen, DJ3
Moccia, M1
Lanzillo, R1
Costabile, T1
Russo, C1
Carotenuto, A1
Sasso, G1
Postiglione, E1
De Luca Picione, C1
Vastola, M1
Maniscalco, GT1
Palladino, R1
Brescia Morra, V1
Molshatzki, N1
Weinstein, G1
Streifler, JY1
Goldbourt, U1
Tanne, D1
Méndez-Hernández, E1
Salas-Pacheco, J1
Ruano-Calderón, L1
Téllez-Valencia, A1
Cisneros-Martínez, J1
Barraza-Salas, M1
Arias-Carrión, O1
Zhang, L1
Li, M1
Zhan, L1
Liang, L1
Su, B1
Sui, H1
Gao, Z1
Li, Y2
Liu, Y1
Wu, B1
Liu, Q1
Cao, B1
Wei, QQ1
Ou, R1
Yang, J1
Shang, HF1
Ye, BS1
Lee, WW1
Ham, JH1
Lee, JJ1
Lee, PH1
Sohn, YH1
Beydoun, MA1
Canas, JA1
Dore, GA1
Beydoun, HA1
Rostant, OS1
Fanelli-Kuczmarski, MT1
Evans, MK1
Zonderman, AB1
Cheung, YT1
Edelmann, MN1
Mulrooney, DA1
Green, DM1
Chemaitilly, W1
John, N1
Robison, LL1
Hudson, MM1
Krull, KR1
Shao, X1
Lu, W1
Gao, F1
Li, D1
Hu, J1
Zuo, Z1
Jie, H1
Zhao, Y1
Cen, X1
Xiu, S1
Zheng, Z1
Guan, S1
Zhang, J2
Ma, J1
Chan, P1
Jinnah, HA2
Gordon, B1
Kraut, M1
Euser, SM1
Hofman, A1
Westendorp, RG1
Breteler, MM1
Irizarry, MC1
Raman, R1
Schwarzschild, MA1
Becerra, LM1
Thomas, RG1
Peterson, RC1
Ascherio, A1
Aisen, PS1
Wang, XJ1
Luo, WF1
Wang, LJ1
Mao, CJ1
Wang, L1
Liu, CF1
Li, J1
Dong, BR1
Lin, P1
Liu, GJ1
Ceballos-Picot, I1
Torres, RJ1
Visser, JE1
Verdu, A1
Laróvere, LE1
Chen, CJ1
Cossu, A1
Wu, CH1
Sampat, R1
Chang, SJ1
de Kremer, RD1
Nyhan, W1
Harris, JC1
Reich, SG1
Puig, JG1
Annanmaki, T2
Pohja, M1
Parviainen, T1
Hakkinen, P1
Murros, K2
Afsar, B1
Elsurer, R1
Covic, A1
Johnson, RJ1
Kanbay, M1
Maetzler, W1
Stapf, AK1
Schulte, C1
Hauser, AK1
Lerche, S1
Wurster, I1
Schleicher, E1
Melms, A1
Berg, D1
Pang, Z1
Jiang, W1
Wang, S1
Tan, Q1
Rinaldi, P1
Polidori, MC1
Metastasio, A1
Mariani, E1
Mattioli, P1
Cherubini, A1
Catani, M1
Cecchetti, R1
Senin, U1
Mecocci, P1
Kim, TS1
Pae, CU1
Yoon, SJ1
Jang, WY1
Lee, NJ1
Kim, JJ1
Lee, SJ1
Lee, C1
Paik, IH1
Lee, CU1
Pessala-Driver, A1
Hokkanen, L1
Waugh, WH1
Cameron, DE1
Oettgen, HF1
Stephenson, PA1
Schwartz, MK1
Leeper, RD1
Tallai, L1
Tan, CC1
Clarkson, BD1
Golbey, RB1
Krakoff, IH1
Karnofsky, DA1
Murphy, ML1
Burchenal, JH1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Vitamin D Status and Intakes and Their Association With Cognitive Trajectory in a Longitudinal Study of Urban Adults[NCT03320109]3,720 participants (Actual)Observational2004-08-18Completed
Lutein Influence on Macula of Persons Issued From Amd Parents[NCT01269697]Phase 3120 participants (Actual)Interventional2011-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for uric acid and Cognition Disorders

ArticleYear
Attenuated variants of Lesch-Nyhan disease.
    Brain : a journal of neurology, 2010, Volume: 133, Issue:Pt 3

    Topics: Adolescent; Adult; Age of Onset; Aged; Child; Child, Preschool; Cognition Disorders; Cohort Studies;

2010
Evolving concepts of memory.
    Recent advances in biological psychiatry, 1966, Volume: 9

    Topics: Aged; Aspartate Aminotransferases; Blood Cell Count; Blood Sedimentation; Clinical Trials as Topic;

1966

Trials

3 trials available for uric acid and Cognition Disorders

ArticleYear
[Study on uric acid and the related factors associated with cognition in the patients with Parkinson's disease].
    Zhonghua yi xue za zhi, 2009, Jun-16, Volume: 89, Issue:23

    Topics: Aged; Cognition Disorders; Female; Humans; Male; Middle Aged; Parkinson Disease; Risk Factors; Uric

2009
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.
    Neurobiology of aging, 2003, Volume: 24, Issue:7

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Apolipoproteins E; Ascorbic Acid; Caroteno

2003
Evolving concepts of memory.
    Recent advances in biological psychiatry, 1966, Volume: 9

    Topics: Aged; Aspartate Aminotransferases; Blood Cell Count; Blood Sedimentation; Clinical Trials as Topic;

1966

Other Studies

30 other studies available for uric acid and Cognition Disorders

ArticleYear
Identification of small molecule compounds with higher binding affinity to guanine deaminase (cypin) than guanine.
    Bioorganic & medicinal chemistry, 2010, Sep-15, Volume: 18, Issue:18

    Topics: Binding Sites; Cognition Disorders; Energy Metabolism; Guanine; Guanine Deaminase; Humans; Kinetics;

2010
Association between uric acid and cognitive dysfunction: A cross-sectional study with newly diagnosed, drug-naïve with bipolar disorder.
    Journal of affective disorders, 2023, 04-14, Volume: 327

    Topics: Bipolar Disorder; Cognition Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Female; Human

2023
The relationship between serum uric acid and cognitive function in patients with chronic heart failure.
    BMC cardiovascular disorders, 2020, 08-20, Volume: 20, Issue:1

    Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Cognition; Cognition Disorders; Cross-Sectiona

2020
A Prospective Study on the Association between Uric Acid and Cognitive Function among Middle-Aged and Older Chinese.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 58, Issue:1

    Topics: Aged; Aged, 80 and over; Asian People; Cognition; Cognition Disorders; Female; Humans; Linear Models

2017
Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment.
    Medical hypotheses, 2018, Volume: 111

    Topics: Acetylcholinesterase; Catalytic Domain; Cognition Disorders; Computational Biology; Disease Progress

2018
Relation between uric acid and Alzheimer's disease in elderly Jordanians.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Female; Geriatrics; Humans; Jordan;

2015
[Cognitive dysfuctions associated with essential tremor and Parkinson's disease].
    Zhonghua yi xue za zhi, 2014, Aug-19, Volume: 94, Issue:31

    Topics: Cognition; Cognition Disorders; Depression; Depressive Disorder; Essential Tremor; Humans; Language;

2014
Higher baseline serum uric acid is associated with poorer cognition but not rates of cognitive decline in women.
    Experimental gerontology, 2014, Volume: 60

    Topics: Aged; Aged, 80 and over; Aging; Biomarkers; Cognition; Cognition Disorders; Cohort Studies; Cross-Se

2014
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
    Journal of neurology, 2015, Volume: 262, Issue:4

    Topics: Adolescent; Adult; Analysis of Variance; Cognition Disorders; Disability Evaluation; Disease Progres

2015
Serum uric acid and subsequent cognitive performance in patients with pre-existing cardiovascular disease.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Cognition Disorders; Female; Humans; Male;

2015
Lower uric Acid linked with cognitive dysfunction in the elderly.
    CNS & neurological disorders drug targets, 2015, Volume: 14, Issue:5

    Topics: Aged; Aged, 80 and over; Aging; Cognition Disorders; Female; Humans; Male; Mental Status Schedule; N

2015
Plasma metabolomic profiling of patients with diabetes-associated cognitive decline.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Aged; Area Under Curve; Bile Acids and Salts; Biomarkers; Case-Control Studies; Chromatography, High

2015
Association of serum uric acid level with cognitive function among patients with multiple system atrophy.
    Journal of the neurological sciences, 2015, Dec-15, Volume: 359, Issue:1-2

    Topics: Aged; Analysis of Variance; Cognition Disorders; Female; Humans; Male; Middle Aged; Multiple System

2015
Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
    European journal of neurology, 2016, Volume: 23, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition Disorders; Cognitive Dysfunction;

2016
Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.
    Journal of Alzheimer's disease : JAD, 2016, 04-21, Volume: 52, Issue:4

    Topics: Adult; Age Factors; Attention; Cognition Disorders; Female; Humans; Longitudinal Studies; Male; Ment

2016
Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Agents; Biomarkers; Cancer Survivors; Cardiovascular Diseases; Cog

2016
Uric Acid Induces Cognitive Dysfunction through Hippocampal Inflammation in Rodents and Humans.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 10-26, Volume: 36, Issue:43

    Topics: Administration, Oral; Animals; Cognition; Cognition Disorders; Cytokines; Encephalitis; Hippocampus;

2016
Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing.
    Neuroscience letters, 2017, 01-10, Volume: 637

    Topics: Aged; Aged, 80 and over; Aging; Beijing; Cognition; Cognition Disorders; Cross-Sectional Studies; Fe

2017
Cerebral ischemia mediates the effect of serum uric acid on cognitive function.
    Stroke, 2008, Volume: 39, Issue:12

    Topics: Adult; Aged; Brain; Brain Edema; Brain Ischemia; Cognition Disorders; Female; Humans; Hyperuricemia;

2008
Serum uric acid and cognitive function and dementia.
    Brain : a journal of neurology, 2009, Volume: 132, Issue:Pt 2

    Topics: Aged; Biomarkers; Cardiovascular Diseases; Cognition Disorders; Dementia; Female; Follow-Up Studies;

2009
Plasma urate and progression of mild cognitive impairment.
    Neuro-degenerative diseases, 2009, Volume: 6, Issue:1-2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Boston; Cognition Disorders; Confounding Factors, Epidem

2009
Association of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians.
    Experimental gerontology, 2010, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Asian People; Cognition Disorders; Cross-Sectional Studies; Female; Humans;

2010
Uric acid and cognition in Parkinson's disease: a follow-up study.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:5

    Topics: Aged; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Ment

2011
Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease.
    American journal of nephrology, 2011, Volume: 34, Issue:1

    Topics: Age Factors; Aged; Cerebrovascular Disorders; Cognition Disorders; Educational Status; Female; Human

2011
Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.
    Journal of Alzheimer's disease : JAD, 2011, Volume: 27, Issue:1

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; ATP Binding Cassette Transporter, Subfamily G, Membe

2011
Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50-74 years.
    Geriatrics & gerontology international, 2013, Volume: 13, Issue:3

    Topics: Aged; Aging; China; Cognition; Cognition Disorders; Cross-Sectional Studies; Disease Progression; Fe

2013
Decreased plasma antioxidants in patients with Alzheimer's disease.
    International journal of geriatric psychiatry, 2006, Volume: 21, Issue:4

    Topics: Aged; Alzheimer Disease; Bilirubin; Biomarkers; Cognition Disorders; Female; Humans; Male; Serum Alb

2006
Uric acid associates with cognition in Parkinson's disease.
    Parkinsonism & related disorders, 2008, Volume: 14, Issue:7

    Topics: Choice Behavior; Cognition Disorders; Female; Humans; Linear Models; Male; Memory; Neuropsychologica

2008
Inhibition of iron-catalyzed oxidations by attainable uric acid and ascorbic acid levels: therapeutic implications for Alzheimer's disease and late cognitive impairment.
    Gerontology, 2008, Volume: 54, Issue:4

    Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Cognition Disorders; Hemoglobins; Hydrogen Peroxide;

2008
Toxicity of E. coli L-asparaginase in man.
    Cancer, 1970, Volume: 25, Issue:2

    Topics: Adult; Agranulocytosis; Antigen-Antibody Reactions; Asparaginase; Blood Platelet Disorders; Bone Mar

1970